Intestinal and microbial components

Intestinal and microbial components represent the collective environment of the gastrointestinal lumen, including the diverse community of microorganisms (microbiota) and the various chemical substances present during digestion (Nature Reviews Gastroenterology & Hepatology, 2020). This category serves as a functional target for therapies that do not interact with a specific host receptor but instead modify the luminal environment or microbial composition. For example, activated charcoal and sevelamer act as physical or chemical binders to remove toxins or excess minerals, respectively (StatPearls, 2023). Meanwhile, agents like rifaximin or fecal microbiota transplants specifically target the microbial population to treat infections or dysbiosis (NIH, 2022). These components are vital for maintaining metabolic homeostasis and immune function, and their disruption is linked to diseases such as inflammatory bowel disease and hepatic encephalopathy (Science, 2019). Because of its heterogeneous nature, this target presents unique challenges in drug development, particularly regarding specificity and the potential for off-target effects on nutrient absorption.

Other names

Gut microbiotaIntestinal contentsIntestinal milieuGastrointestinal microbiomeLuminal contents

Modulation of the gastrointestinal environment through physical adsorption, chemical sequestration, or alteration of microbial population dynamics.